TRU-SENTIMENT · DeltaNeutral
AXGN Trading Analysis - 10/19/2026 01:46 PM — TRU-SENTIMENT
Options chain · Stock chart · Baseline chart
AXGN (Axogen Inc. Common Stock) at $34.59. True Sentiment Bearish, delta 40-60 call 12% / put 88%, call $4,390 vs put $31,240. RSI 12.4.
- Symbol
- AXGN
- Price
- $34.59
- Article bias (separate from True Sentiment)
- bearish
- Conviction
- medium
- Published
- 2026-10-19 13:46:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options)From 2026-10-19 options flow (Delta 40-60 only):
Call Volume: $4,390 (12.3%) Put Volume: $31,240 (87.7%) Total: $35,630
- Sentiment: Bearish (87.7% put dollar vol).
- Contracts: 9 calls vs 38 puts; only 4 of 90 options analyzed met filter (4.4% pure conviction).
- Read: Strong directional put conviction near-term; aligns with price below SMAs and RSI oversold-but-falling.
- Divergence: Option spread engine flagged "Divergence detected between technical indicators and options sentiment" — technically oversold (RSI 12) yet sentiment bearish; no clear directional tech signal per engine.
Key Statistics: AXGN
Fundamental Snapshot
Valuation
| EPS (trailing 12 mo) | $-0.66 |
| Market cap | $2.03B |
| Shares outstanding | 58.7M |
Dividend
| Dividend yield | 0.00% |
| Ex-dividend date | 2010-01-27 |
Risk & range
| Beta | 1.90 |
| 52-week low | $16.23 |
| 52-week high | $52.91 |
| Historical volatility | 51.7% |
Ownership & trading
| Institutional ownership | 55.9% |
| Average daily volume | 1.5M sh |
Reported figures; no analyst estimates.
📈 Analysis
News Headlines & Context
Based on general knowledge of Axogen (AXGN), a regenerative medicine company focused on peripheral nerve repair, recent relevant context includes:
- AXGN has historically been impacted by hospital procedure volumes; late 2026 recovery in elective surgeries may support revenue, though no specific recent earnings date is confirmed in provided data.
- Previous commentary from 2025 indicated continued net losses as the company scaled commercial operations; negative EPS trajectory aligns with fundamentals shown.
- Potential Medicare reimbursement changes for nerve grafts have been a recurring catalyst watched by investors in the regenerative med space.
- No specific near-term binary event (e.g., FDA decision) is known from provided data, but high beta (1.90) suggests sensitivity to broader biotech sentiment.
- Context: Heavy put positioning in options (87.7% put dollar vol) may reflect defensive positioning amid soft price trends, not necessarily a new fundamental negative.
Fundamental Analysis
From embedded FUNDAMENTALS data (2026-10-19):
- Trailing EPS: -0.66 (company unprofitable, no positive earnings).
- Trailing P/E: null; Forward P/E: null; PEG: null — standard valuation ratios not available due to negative earnings.
- Market Cap: $2,029,464,480; Shares Out: 58,672,000; Institutional Ownership: 55.91%.
- Dividend Yield: 0.00% (no income).
- 52-Week High: $52.91; 52-Week Low: $16.24 — current price ~34.49 near lower half of range.
- Beta: 1.90 (high volatility vs market).
- Historical Volatility: 51.73%.
- Revenue Growth, Margins, ROE, Debt/Equity, FCF: null in data (not disclosed in feed).
- Analyst Target / Consensus: null (no recommendation key or mean target provided).
Fundamentals show a loss-making small-cap med device name with no standard valuation anchor. This diverges from any bullish technical setup since price is below all SMAs and sentiment is bearish.
Current Market Position
Current price per indicators: $34.49 (2026-10-16 close). Minute bars show 2026-10-19 13:15 last close $34.59, drifting from $35.40 at 2026-10-16 09:30 open. Intraday 10-19 range $34.53–$34.59 in final bars, low momentum.
Daily history: 30-day high $48.38 (2026-09-04), low $34.40 (2026-10-16). Price sits at bottom of 30-day range.
Technical Analysis
Technical Indicators
- SMA alignment: Price $34.49 < SMA5 $35.72 < SMA20 $39.33 < SMA50 $44.43 — full bearish stack, no bullish crossovers.
- RSI 12.44: deeply oversold, bearish momentum extreme.
- MACD: -2.62 below signal -2.09, histogram -0.52 (negative, bearish).
- Bollinger: Mid $39.33, Upper $46.75, Lower $31.92 — price below lower band extension, weak.
- 30-day range: price at $34.49, just above low $34.40 (bottom 2% of range).
True Sentiment Analysis (Delta 40-60 Options)
From 2026-10-19 options flow (Delta 40-60 only):
Call Volume: $4,390 (12.3%) Put Volume: $31,240 (87.7%) Total: $35,630
- Sentiment: Bearish (87.7% put dollar vol).
- Contracts: 9 calls vs 38 puts; only 4 of 90 options analyzed met filter (4.4% pure conviction).
- Read: Strong directional put conviction near-term; aligns with price below SMAs and RSI oversold-but-falling.
- Divergence: Option spread engine flagged "Divergence detected between technical indicators and options sentiment" — technically oversold (RSI 12) yet sentiment bearish; no clear directional tech signal per engine.
Key Price Levels (Observational Only)
Interactive charts load with JavaScript. This text is the crawlable summary.